Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines

Adv Exp Med Biol. 1994:370:139-43. doi: 10.1007/978-1-4615-2584-4_32.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / toxicity*
  • Cell Division / drug effects
  • Cell Line
  • Cisplatin / toxicity*
  • Colonic Neoplasms
  • Cytidine Deaminase
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / toxicity
  • Deoxycytidine Kinase / metabolism
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Female
  • Gemcitabine
  • Humans
  • Kinetics
  • Mice
  • Nucleoside Deaminases / metabolism
  • Ovarian Neoplasms
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Deoxycytidine Kinase
  • Nucleoside Deaminases
  • Cytidine Deaminase
  • deoxycytidine deaminase
  • Cisplatin
  • Gemcitabine